So MAPS embarked on a many years-very long work to prove that the drug experienced merit as a medicine, boosting $one hundred forty million from donors to purchase clinical trials. The Group formed what on earth is now Lykos ten years ago as a public-advantage corporation, in anticipation that MDMA-